Fidelity Investments
DRUG

Fidelity Investments’s Bright Minds Biosciences DRUG Stock Holding History

Fidelity Investments’s Portfolio DRUG Stock Details DRUG Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$59.8K Sell
819
-292
-26% -$23.5K ﹤0.01% 4041
2025
Q4 		$86.7K Buy
1,111
+460
+71% +$30.7K ﹤0.01% 3833
2025
Q3 		$39.5K Buy
651
+572
+724% +$22.2K ﹤0.01% 4083
2025
Q2 		$2.06K Buy
+79
New +$2.37K ﹤0.01% 4857

Other funds holding DRUG

Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
CAM
Cormorant Asset Management Boston, Massachusetts $1.99B AUM 737.95% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VC
Vivo Capital Palo Alto, California $1.2B AUM 911.44% 1-Year Est. Return
B
Braidwell Stamford, Connecticut $3B AUM 46.72% 1-Year Est. Return
Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return
VPC
Vestal Point Capital New York $3.58B AUM 189.12% 1-Year Est. Return
DCM
Driehaus Capital Management Chicago, Illinois $13.6B AUM 173.98% 1-Year Est. Return
PA
Perceptive Advisors New York $5.12B AUM 314.02% 1-Year Est. Return
Balyasny Asset Management
Balyasny Asset Management Chicago, Illinois $77.1B AUM 42.89% 1-Year Est. Return

Fidelity Investments's DRUG Position: Q1 2026 in Review

Fidelity Investments reduced its Bright Minds Biosciences (DRUG) stake by 26% in Q1 2026, selling an estimated $23.5K and leaving 819 shares worth $59.8K. The position accounts for ﹤0.01% of the portfolio, ranked #4041.

Fidelity Investments first reported a position in DRUG in Q2 2025 and has held it in 4 quarters since. The position peaked at $86.7K in Q4 2025. 94 funds tracked by Wall St. Rank hold DRUG as of Q1 2026.

  • Fidelity Investments held 819 shares of Bright Minds Biosciences worth $59.8K as of Q1 2026.
  • Fidelity Investments sold 292 Bright Minds Biosciences shares in Q1 2026, an estimated $23.5K.
  • Bright Minds Biosciences made up ﹤0.01% of Fidelity Investments's portfolio in Q1 2026, its #4041 holding.
  • Fidelity Investments first reported a position in Bright Minds Biosciences in Q2 2025 and has held it in 4 quarters since.
  • Fidelity Investments's Bright Minds Biosciences position peaked at $86.7K in Q4 2025.
  • 94 funds tracked by Wall St. Rank held Bright Minds Biosciences as of Q1 2026.

Based on Fidelity Investments's 13F filing for Q1 2026, filed 15 May 2026.